Variant report
Variant | nsv524465 |
---|---|
Chromosome Location | chr19:51360087-51363398 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:61)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr19:51362299-51362577 | MCF-7 | breast: | n/a | n/a |
2 | CTCF | chr19:51362306-51362309 | MCF-7 | breast: | n/a | n/a |
3 | CTCF | chr19:51362311-51362594 | MCF-7 | breast: | n/a | n/a |
4 | CTCF | chr19:51362272-51362580 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr19:51362435-51362575 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CTCF | chr19:51362320-51362470 | MCF-7 | breast: | n/a | n/a |
7 | CTCF | chr19:51362393-51362562 | MCF-7 | breast: | n/a | n/a |
8 | CTCF | chr19:51362400-51362550 | NHEK | skin: | n/a | n/a |
9 | CTCF | chr19:51362413-51362597 | LNCaP | prostate: | n/a | n/a |
10 | CTCF | chr19:51362437-51362572 | MCF-7 | breast: | n/a | n/a |
11 | ELF1 | chr19:51363194-51363500 | K562 | blood: | n/a | chr19:51363339-51363352 |
12 | JUND | chr19:51361758-51361958 | HepG2 | liver: | n/a | chr19:51361852-51361861 chr19:51361853-51361860 chr19:51361850-51361861 |
13 | MAX | chr19:51362100-51362479 | MCF-7 | breast: | n/a | n/a |
14 | MYC | chr19:51361480-51361483 | MCF-7 | breast: | n/a | n/a |
15 | MYC | chr19:51362504-51362524 | MCF-7 | breast: | n/a | n/a |
16 | MYC | chr19:51362354-51362406 | MCF-7 | breast: | n/a | n/a |
17 | MYC | chr19:51362530-51362580 | MCF-7 | breast: | n/a | n/a |
18 | MYC | chr19:51362236-51362423 | MCF-7 | breast: | n/a | n/a |
19 | MYC | chr19:51362642-51362650 | MCF-7 | breast: | n/a | n/a |
20 | MYC | chr19:51361494-51361506 | MCF-7 | breast: | n/a | n/a |
21 | MYC | chr19:51362409-51362419 | MCF-7 | breast: | n/a | n/a |
22 | MYC | chr19:51362261-51362472 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr19:51361725-51361728 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr19:51362413-51362511 | MCF-7 | breast: | n/a | n/a |
25 | POLR2A | chr19:51362538-51362962 | MCF-7 | breast: | n/a | n/a |
26 | POLR2A | chr19:51361760-51361773 | MCF-7 | breast: | n/a | n/a |
27 | POLR2A | chr19:51361802-51361856 | MCF-7 | breast: | n/a | n/a |
28 | POLR2A | chr19:51363263-51363328 | MCF-7 | breast: | n/a | n/a |
29 | SIN3A | chr19:51362172-51362313 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | TBP | chr19:51363149-51363250 | K562 | blood: | n/a | n/a |
31 | TCF12 | chr19:51362195-51362462 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51362954-51363004 | Caco-2 | colon: | n/a |
2 | chr19:51362954-51363004 | LNCaP | prostate: | n/a |
3 | chr19:51362954-51363004 | RPTEC | kidney: | n/a |
4 | chr19:51362954-51363004 | PFSK-1 | brain: | n/a |
5 | chr19:51362954-51363004 | PANC-1 | pancreas: | n/a |
6 | chr19:51362954-51363004 | AG10803 | skin: | n/a |
7 | chr19:51362954-51363004 | HAEpiC | amniotic membrane: | n/a |
8 | chr19:51362954-51363004 | NT2-D1 | testis: | n/a |
9 | chr19:51362954-51363004 | PrEC | prostate: | n/a |
10 | chr19:51362954-51363004 | HCF | heart: | n/a |
11 | chr19:51362954-51363004 | ProgFib | skin: | n/a |
12 | chr19:51362954-51363004 | U87 | brain: | n/a |
13 | chr19:51362954-51363004 | A549 | lung: | n/a |
14 | chr19:51362954-51363004 | HL-60 | blood: | n/a |
15 | chr19:51362954-51363004 | BJ | skin: | n/a |
16 | chr19:51362954-51363004 | ECC-1 | luminal epithelium: | n/a |
17 | chr19:51362954-51363004 | NHDF-neo | bronchial: | n/a |
18 | chr19:51362954-51363004 | HCPEpiC | choroid plexus: | n/a |
19 | chr19:51362954-51363004 | AG09309 | skin: | n/a |
20 | chr19:51362954-51363004 | SK-N-MC | brain: | n/a |
21 | chr19:51362954-51363004 | MCF-7 | breast: | n/a |
22 | chr19:51362954-51363004 | T-47D | breast: | n/a |
23 | chr19:51362954-51363004 | HRE | kidney: | n/a |
24 | chr19:51362954-51363004 | AG09319 | gingival: | n/a |
25 | chr19:51362954-51363004 | HCM | heart: | n/a |
26 | chr19:51362954-51363004 | HNPCEpiC | eye: | n/a |
27 | chr19:51362954-51363004 | AoSMC | blood vessel: | n/a |
28 | chr19:51362954-51363004 | AG04450 | lung: | fetal |
29 | chr19:51362954-51363004 | HMEC | breast: | n/a |
30 | chr19:51362954-51363004 | NB4 | blood: | n/a |
31 | chr19:51362954-51363004 | HEEpiC | esophagus: | n/a |
32 | chr19:51362954-51363004 | GM12878 | blood: | n/a |
33 | chr19:51362954-51363004 | Hela-S3 | cervix: | n/a |
34 | chr19:51362954-51363004 | HIPEpiC | eye: | n/a |
35 | chr19:51362954-51363004 | HepG2 | liver: | n/a |
36 | chr19:51362954-51363004 | SK-N-SH | brain: | n/a |
37 | chr19:51362954-51363004 | Hepatocyte | liver: | n/a |
38 | chr19:51362954-51363004 | AG04449 | skin: | fetal |
39 | chr19:51362954-51363004 | NH-A | brain: | n/a |
40 | chr19:51362954-51363004 | SAEC | small airway: | n/a |
41 | chr19:51362954-51363004 | BE2_C | brain: | n/a |
42 | chr19:51362954-51363004 | SKMC | muscle: | n/a |
43 | chr19:51362954-51363004 | MCF10A-Er-Src | breast: | n/a |
44 | chr19:51362954-51363004 | HPAEpiC | pulmonary alveolar: | n/a |
45 | chr19:51362954-51363004 | Jurkat | blood: | n/a |
46 | chr19:51362954-51363004 | GM12892 | blood: | n/a |
47 | chr19:51362954-51363004 | HEK293 | kidney: | embryo |
48 | chr19:51362954-51363004 | GM12891 | blood: | n/a |
49 | chr19:51362954-51363004 | K562 | blood: | n/a |
50 | chr19:51362954-51363004 | SK-N-SH_RA | brain: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51357627..51359895-chr19:51362884..51364661,2 | K562 | blood: | |
2 | chr19:51300732..51302357-chr19:51358771..51360545,2 | K562 | blood: | |
3 | chr19:51335920..51338243-chr19:51361874..51364781,2 | K562 | blood: | |
4 | chr19:51296075..51301998-chr19:51356744..51362542,6 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KLK2 | TF binding region |
KLK3 | TF binding region |
KLK2 | CpG island |
KLK3 | CpG island |
ENSG00000142515 | chromatin interactions |
ENSG00000268375 | chromatin interactions |
ENSG00000174562 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1061476 | chr19:51360087-51360088 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs112526646 | chr19:51360092-51360093 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs1061477 | chr19:51360096-51360097 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs572763492 | chr19:51360097-51360098 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs531392134 | chr19:51360141-51360142 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs185263651 | chr19:51360144-51360145 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs532525400 | chr19:51360145-51360146 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs370778081 | chr19:51360167-51360168 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs111443720 | chr19:51360216-51360217 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs550802310 | chr19:51360244-51360245 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs562639546 | chr19:51360276-51360277 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs530161760 | chr19:51360279-51360280 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs540393407 | chr19:51360280-51360281 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs3180017 | chr19:51360351-51360352 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs566830870 | chr19:51360367-51360368 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs527689854 | chr19:51360373-51360374 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs578067733 | chr19:51360399-51360400 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs560492067 | chr19:51360401-51360402 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs191177367 | chr19:51360414-51360415 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs368857038 | chr19:51360415-51360416 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs372296728 | chr19:51360416-51360417 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs376594258 | chr19:51360417-51360418 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs560911495 | chr19:51360418-51360419 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs367739584 | chr19:51360419-51360420 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs544196970 | chr19:51360433-51360434 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs183843178 | chr19:51360435-51360436 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs567190839 | chr19:51360439-51360440 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs113476261 | chr19:51360440-51360441 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs372329134 | chr19:51360445-51360446 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs143944639 | chr19:51360464-51360465 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs562883894 | chr19:51360520-51360521 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs34314580 | chr19:51360533-51360534 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs557224433 | chr19:51360676-51360677 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs147384587 | chr19:51360743-51360744 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs530333270 | chr19:51360744-51360745 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs112956468 | chr19:51360759-51360760 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs266877 | chr19:51360768-51360769 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs112258520 | chr19:51360770-51360771 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs187193902 | chr19:51360787-51360788 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs374752282 | chr19:51360788-51360789 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs539854914 | chr19:51360811-51360812 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs266876 | chr19:51360818-51360819 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs62113212 | chr19:51360840-51360841 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs544376828 | chr19:51360856-51360857 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs562775417 | chr19:51360872-51360873 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs147998938 | chr19:51360893-51360894 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs191988185 | chr19:51360952-51360953 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs112225901 | chr19:51360959-51360960 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs560392991 | chr19:51361074-51361075 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs570507509 | chr19:51361094-51361095 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17160897 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Lung cancer | 18438408 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51358000-51361400 | Weak transcription | Pancreas | Pancrea |
2 | chr19:51359400-51360600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr19:51360600-51361200 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
4 | chr19:51360600-51361200 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr19:51360600-51361400 | Enhancers | GM12878-XiMat | blood |
6 | chr19:51360600-51362800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr19:51360600-51363000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr19:51361000-51361400 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr19:51361000-51361400 | Weak transcription | Esophagus | oesophagus |
10 | chr19:51361000-51362000 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
11 | chr19:51361200-51361600 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
12 | chr19:51361400-51361600 | Bivalent Enhancer | Right Ventricle | heart |
13 | chr19:51361400-51362800 | Enhancers | Pancreas | Pancrea |
14 | chr19:51361400-51364800 | Enhancers | Esophagus | oesophagus |
15 | chr19:51361600-51363000 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr19:51361800-51362000 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
17 | chr19:51361800-51362600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
18 | chr19:51362000-51362200 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
19 | chr19:51362000-51362200 | Bivalent Enhancer | Fetal Intestine Large | intestine |
20 | chr19:51362000-51362800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
21 | chr19:51362200-51362400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
22 | chr19:51362400-51362600 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
23 | chr19:51362600-51363000 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
24 | chr19:51362800-51364400 | Weak transcription | Pancreas | Pancrea |